To solve cancer, we need to solve data. Despite the abundance of cancer research data, translating this into precision medicine is challenging.
Concr is a platform technology facilitating cross-talk between biopharma, diagnostic companies and healthcare providers through data.
Our unique astrophysics-based methodology allows iterative learning between multiple and disparate data sources throughout all stages of a drug journey into the clinic — from pre-clinical development to post-approval.
Proven technology with decades of use in astrophysics
Integrating disparate data and tests from across the pipeline and different indications
Minimal data input per patient
Patient outcome-centred with added value explicitly calculated
less pre-clinical data
less clinical trial data
Minimal data needed to make actionable predictions on biomarker response at early and pre-disease stages.
Enabling systematic contribution and democratised access to an outcome-based valuation of models (analytics) and data (assets) for stakeholders.
We are a diverse group of world leaders and pioneers spanning three generations. We have been curated to answer the hardest questions in precision oncology translation and application.
If you are interested in working with us, participating in a pilot program or investing in Concr please get in touch: